Table 1. Geriatric Assessment Domains, Definitions, and Importance.
Domain | Definitions | Importance |
---|---|---|
Comorbidities | Mention of chronic illnesses not including cancer. | Comorbidities are associated with poorer overall survival and poor treatment tolerance. |
Polypharmacy | Mention of other OTC or prescription drugs. | Polypharmacy increases the risk of drug-drug interactions. |
Nutrition | Mention of weight, appetite, eating, oral health. | Poor nutritional status is associated with increased need for functional assistance and poorer survival. Unintentional weight loss 6 months before chemotherapy is associated with lower chemotherapy response rates and lower overall survival. |
Physical performance | Mention of exercise, mobility, strength, falls. | Falls are predictive of worse outcomes. |
Functional status | Mention of ADLs or IADLs. | Poor functional status is predictive of chemotherapy toxicity and lower survival. |
Social support | Mention of instrumental (e.g., financial, transportation) or emotional support. | Poor social support could impact adherence to treatment and decrease quality of life. |
Cognition | Mention of ability to make decisions, memory issues, or confusion. | Poor cognition can influence adherence to treatment, understanding of the risks and benefits of treatment, and the ability to make decisions. |
Mental health | Mention of mood, depression, or anxiety. | Psychological distress can influence patients’ physical performance. |
Note. OTC = over the counter; ADLs = activity of daily living; IADLs = independent activity of daily living.